-

Safety

  • Share Share this page

Femara (letrozole) 2.5 mg tablets

 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009

 

Summary View

 

ADVERSE REACTIONS

Post-Marketing Experiences
    
-
-
-
-
-